Table 3: Serotype and macrolide resistance distribution.
|
cMLS(B) Phenotype |
iMLS(B) phenotype |
M phenotype |
Prevalence |
Serotype I |
1 (50%) |
1(50%) |
0% |
2 (5.1%) |
Serotype II |
4 (80%) |
1 (20%) |
0% |
5 (12.8%) |
Serotype III |
9 (69.2%) |
3 (23.1%) |
1 (7.7%) |
13 (33.3%) |
Other serotypes |
17 (89.5%) |
0% |
2 (10.5%) |
19 (48.7%) |
Total |
31(79.4%) |
5 (12.8%) |
3 (7.7%) |
39 (100%) |